-
UPDATE: Citi Raises PT on Laboratory Corp of America to $101
Monday, May 23, 2011 - 7:21am | 106Citi is out with its report today on Laboratory Corp of America (NYSE: LH), raising its PT from $89 to $101. In a note to clients, Citi writes, "LH shares have outperformed into and through the 1Q11 results last month, leaving our 12/1/10 $86 downgrade in the dust. Today we've revisited and...
-
Citigroup Raises PT On Laboratory Corporation of America To $101
Monday, May 23, 2011 - 6:01am | 28Citigroup has raised the price target on Laboratory Corporation of America (NYSE: LH) from $89 to $101 and maintains its Hold rating.
-
Quest Diagnostics Finalizes Agreement to Settle California Lawsuit Related to Medi-Cal Billing
Thursday, May 19, 2011 - 5:00pm | 97Quest Diagnostics Incorporated (NYSE: DGX) today announced it has finalized an agreement to settle a previously disclosed civil lawsuit, brought by a California competitor against a number of California clinical laboratories, in which the State of California intervened, for a payment of $241...
-
J.P. Morgan Maintains Overweight on Express Scripts
Thursday, May 19, 2011 - 7:54am | 159J.P. Morgan is out with its report today on Express Scripts (NASDAQ: ESRX), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on Express Scripts shares is Overweight. We continue to point to the positive fundamental outlook for the PBM industry, based on the opportunity...
-
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Wednesday, May 18, 2011 - 8:06am | 102Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 1, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May 17,...
-
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark
Wednesday, May 18, 2011 - 8:00am | 102Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 1, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May 17,...
-
10 Stocks Billionaire Steven Cohen Is Buying
Tuesday, May 17, 2011 - 2:00pm | 246(TheStreet) -- Steven Cohen's SAC Capital, known for its trading-oriented style to investing, made big bets in the first quarter while adding to key positions in Newmont Mining (NYSE: NEM) and communications company CenturyLink (NYSE: CTL). Cohen's Stamford, Conn.-based hedge fund firm, which...
-
Kindred Healthcare Reports Senior Notes Offering Up to $550M (KND, RHB)
Monday, May 16, 2011 - 7:06am | 140Kindred Healthcare(NYSE: KND) today announced that it is planning to issue an aggregate principal amount of up to $550 million of senior notes due 2019 to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended and to certain non-United States...
-
Is Select Medical Holdings (SEM) stocks worth buying right now?
Monday, May 16, 2011 - 6:40am | 1350Over the past 12 months Select Medical Holdings Corporation (SEM), specialty hospitals and outpatient rehabilitation clinics operator, has made $103.7 million cash with net income of $87.1 million, it turned 4.1% of its revenue into FCF. Select Medical is trading at a price of $9.00, a dramatic...
-
CEOWORLD stock picks that will outperform the S&P 500- BRK-B, SAM, LUK, NYB, SYY, BAX, LVB, RSO, UAN…
Monday, May 16, 2011 - 5:35am | 1362Boston Beer Company (SAM)- Trailing-12-Month Revenue- $471.9 million, Return on Equity (Average, Past 3 Years)- 20.5%, Cash/Debt, $45.3 million / $0, Competitors- Anheuser-Busch (BUD), Molson Coors (TAP). Boston Beer Company is trading at a price of $84.15, a dramatic change of -0.87 with %...
-
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Operating Margin (LH, DGX, PPDI, CVD)
Monday, May 16, 2011 - 12:42am | 131Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Laboratory Corp. of America Holdings (NYSE: LH) is 20.02%. LH's ROE for the same period is 24.61%. The trailing-twelve-month...
-
PDI Announces David Kerr, SVP, Business Development, to Leave
Friday, May 13, 2011 - 4:33pm | 62PDI, Inc. (Nasdaq: PDII) today announced that, effective June 3, David Kerr, Senior Vice President of Business Development, will be leaving the company for family reasons. PDI has begun a search for his replacement, and Kerr will provide assistance in the transition process. Kerr has been in his...
-
UPDATE: Deutsche Bank Raises PT on DaVita to $102 (DVA)
Friday, May 13, 2011 - 7:39am | 128Deutsche Bank is out with its report today on DaVita (NYSE: DVA), raising its PT from $101 to $102. In a note to clients, Deutsche Bank writes, "As a somewhat belated follow up to Q1 results, we are introducing an updated model. While we've made some changes to assumptions which result in a 3%...
-
Deutsche Bank Raises PT On DaVita To $102
Friday, May 13, 2011 - 6:18am | 26Deutsche Bank has raised the price target on DaVita (NYSE: DVA) from $101 to $102 and maintains its Buy rating.
-
Catalyst Rx Announces PBM Contract Award by State of Nevada
Thursday, May 12, 2011 - 9:01am | 103Catalyst Rx, the pharmacy benefit management subsidiary of Catalyst Health Solutions, Inc. (NASDAQ: CHSI), today announced the award of a new service contract with the State of Nevada Public Employees' Benefits Program, following the State's competitive bid process. The new contract, covering 42,...